NCBiotech News

TARGAN, a Morrisville biotech startup that is focused on revolutionizing current vaccination methods for the commercial poultry industry, has landed an additional $35 million in funding.

Morrisville gene editing startup Locus Biosciences is another step closer to actualizing its biotherapeutics against bacterial diseases after landing $35 million in additional capital.

Labcorp’s new at-home collection kit is a threefer. It simultaneously tests for COVID-19, respiratory syncytial virus (RSV) and the flu, too.

When the pandemic caused Frankie Spinks to lose her job, she found a new career opportunity in biomanufacturing through the BioWork certificate program at Central Carolina Community College.

The keynote speaker, co-chairs, events team and awards committee have been selected for the June 23 Triad BioNight 2022.

Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies

AgBiome is turning to an Ohio startup, 3Bar Biologics, to partner on 3Bar's biologics delivery system that essentially brings a key part of the laboratory to the farm field.

RTP-based ag tech company Vestaron is gaining market traction with its peptide biopesticide, and has raised $82 million in financing to support commercialization of its current product lineup and fuel the R&D of new products.

North Carolina has scored top honors for its recruitment efforts for the second year in a row, landing Site Selection magazine’s 2021 Prosperity Cup,

A new industrial consortium led by the North Carolina Biotechnology Center will develop apprenticeships in the life sciences to strengthen workforce preparedness.

Durham-based Humacyte is providing engineered blood vessels to multiple hospitals in Ukraine for treating wounded civilians and soldiers with vascular injuries suffered in the Russian invasion.

North Carolina is vying for up to $75 million in funding as part of the US EDA's “Build Back Better Regional Challenge.” This week, NC got to make its case in person.

Eastern North Carolina leaders are investing in the region’s growing entrepreneurial community as sponsors of NCBiotech's NC BIONEER Venture Challenge

Durham-based Mycovia Pharmaceuticals has received its first product approval from the FDA -- for VIVJOA, an oral antifungal capsule for treating recurrent vaginal yeast infections in women who have no reproductive capacity.

BASF has cut the ribbon on a 5,500-square-foot center dedicated to promoting sustainable agriculture, which is now open to the public in the heart of the Research Triangle.